When joint troubles jeopardize a horse’s ability to run, they affect more than tissue and bone. They affect the very essence of being a horse. That’s why Boehringer Ingelheim offers a trusted portfolio of complementary joint care products to promote joint health and long, healthy lives for horses.
Learn about what makes Surpass unique.
Surpass® (1% diclofenac sodium) is an easy-to-apply cream and the only FDA-approved veterinary product containing diclofenac, a potent pain reducer and anti-inflammatory agent.
Hyvisc® (hyaluronate sodium) is an injectable product that mimics the properties of synovial fluid naturally found in joints to provide lubrication and reduce inflammation.
Hyalovet® (hyaluronate sodium) has been trusted since 1988 to provide a predictable clinical response for intra-articular treatment of carpal or fetlock joint dysfunction.
Vetalog® Parenteral
(sterile triamcinolone acetonide
suspension USP) is an injectable steroid veterinarians have relied on for decades for fast pain relief.
To receive the latest information on our equine joint health educational opportunities and equine joint products…
As with any prescription medication, a veterinarian should review the medical history of the horse and perform a medical exam prior to use.
When using Hyvisc or Hyalovet, as with all intra-articular injections, care should be taken to ensure aseptic technique. There are no known contraindications to the use of Hyvisc or Hyalovet.
Surpass is not for use in horses intended for human consumption. As a class, NSAIDs may be associated with gastrointestinal and renal toxicity.
Vetalog Parenteral should not be used to alleviate pain or reduce inflammation arising from infectious states unless concomitant antimicrobial therapy is given. Because of the anti-inflammatory action of corticosteroids, signs of infection may be hidden and it may be necessary to stop treatment until diagnosis is made. Do not use with viral infections.